For Medical
Community

Studying, researching and treating migraine
and other headaches.

What EMHA can do for the medical community

As an alliance of patient associations, we can learn at the source what the main concerns and pain points of migraine patients are.


Our aim is to work together with the medical community to improve the quality of life of the migraine patient, as well as to advocate for the dissemination of reliable information and promote further research into this disease.

EMHA PROJECTS

Raising awareness to change the future under #TheMigraineMovement

Stigma survey 2023

Migraine & Stigma Survey 2023 In 2023, the EMHA conducted a comprehensive pan-European digital survey answered by 4.210 people across 17 countries. In order to examinate the origins of stigma surrounding migraine, its impact on patients, and their need for better understanding and support. The survey covers various topics such as patients’ ease in sharing

VIEW PROJECT

Access to care survey 2021

The EMHA worked along KPMG on a market research to understand the patient journey and burden of disease for migraine in 12 countries. The Access to care survey 2021 has shown insightful results on the patients’ access to treatment and care in each of their country. Summary of the “Access To Care III” survey results

VIEW PROJECT

Women at work

In 2018 EMHA organised a survey among migraine patients working in 7 EU countries (Ireland, Italy, France, Germany, Portugal, Spain and United Kingdom.
The survey shed light on how women have to juggle between migraine attacks and work.

VIEW PROJECT

The Migraine Assistant

After launching The Migraine Movement Manifesto, from EMHA, we set the goal to inform the largest amount of European migraine sufferers about the existence of that movement, born with the aim of giving them visibility, answers and support.

VIEW PROJECT

Explaining Migraine

We realized that the words we normally use to describe our relationship with migraine simply fall short to convey the true feeling behind. Words like “pain” or “horror”, commonly used to describe a migraine, ended up being generic adjectives that linked our disease to a simple headache.

VIEW PROJECT

The Missing Lesson

The lack of medical training is the main barrier for an accurate diagnosis when a possible migraine patient first visits a doctor. In the world, only 4 hours of migraine are studied in medical training.

VIEW PROJECT
COLLABORATIVE SUPPORTERS GUIDELINES
(A-Z)

Working with the pharmaceutical and biotech industries.

Abbvie

Curelator

Grunenthal

Lilly

Lundbeck

Novartis

Sanofi

Teva

Scroll to Top